News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,370 Results
Type
Article (41435)
Company Profile (264)
Press Release (685657)
Multimedia
Podcasts (86)
Webinars (20)
Section
Business (204879)
Career Advice (2053)
Deals (35575)
Drug Delivery (121)
Drug Development (81525)
Employer Resources (173)
FDA (16535)
Job Trends (14998)
News (346996)
Policy (32830)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2591)
Accelerated approval (42)
Adcomms (25)
Allergies (160)
Alliances (49632)
ALS (193)
Alzheimer's disease (1741)
Antibody-drug conjugate (ADC) (366)
Approvals (16853)
Artificial intelligence (595)
Autoimmune disease (223)
Automation (50)
Bankruptcy (362)
Best Places to Work (11657)
BIOSECURE Act (20)
Biosimilars (201)
Biotechnology (174)
Bladder cancer (177)
Brain cancer (63)
Breast cancer (685)
Cancer (5307)
Cardiovascular disease (450)
Career advice (1740)
Career pathing (39)
CAR-T (300)
CDC (54)
Celiac Disease (2)
Cell therapy (797)
Cervical cancer (41)
Clinical research (70278)
Collaboration (1886)
Company closure (4)
Compensation (1283)
Complete response letters (69)
COVID-19 (2727)
CRISPR (98)
C-suite (974)
Cystic fibrosis (148)
Data (7041)
Decentralized trials (3)
Denatured (26)
Depression (153)
Dermatology (57)
Diabetes (550)
Diagnostics (6827)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (292)
Drug pricing (194)
Drug shortages (29)
Duchenne muscular dystrophy (266)
Earnings (91079)
Editorial (61)
Employer branding (21)
Employer resources (152)
Events (118397)
Executive appointments (1030)
FDA (19954)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1610)
Gene editing (210)
Generative AI (52)
Gene therapy (651)
GLP-1 (1015)
Government (4710)
Grass and pollen (6)
Guidances (396)
Healthcare (18957)
HIV (73)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (271)
Immuno-oncology (80)
Indications (157)
Infectious disease (3039)
Inflammatory bowel disease (200)
Inflation Reduction Act (14)
Influenza (128)
Intellectual property (273)
Interviews (322)
IPO (16653)
IRA (50)
Job creations (3657)
Job search strategy (1448)
JPM (58)
Kidney cancer (18)
Labor market (92)
Layoffs (553)
Leadership (36)
Legal (7975)
Liver cancer (98)
Longevity (28)
Lung cancer (712)
Lymphoma (408)
Machine learning (52)
Management (59)
Manufacturing (918)
MASH (176)
Medical device (13906)
Medtech (13984)
Mergers & acquisitions (20079)
Metabolic disorders (1407)
mRNA (174)
Multiple sclerosis (172)
NASH (17)
Neurodegenerative disease (381)
Neuropsychiatric disorders (98)
Neuroscience (3128)
Neurotech (1)
NextGen: Class of 2026 (6533)
Non-profit (4528)
Now hiring (73)
Obesity (661)
Opinion (280)
Ovarian cancer (185)
Pain (227)
Pancreatic cancer (253)
Parkinson's disease (336)
Partnered (33)
Patents (552)
Patient recruitment (587)
Peanut (60)
People (59251)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (21905)
Phase 2 (30939)
Phase 3 (23048)
Pipeline (7100)
Policy (304)
Postmarket research (2569)
Preclinical (9281)
Press Release (64)
Prostate cancer (274)
Psychedelics (49)
Radiopharmaceuticals (302)
Rare diseases (990)
Real estate (5966)
Recruiting (70)
Regulatory (25012)
Reports (54)
Research institute (2410)
Resumes & cover letters (354)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (164)
Series A (266)
Series B (200)
Service/supplier (11)
Sickle cell disease (106)
Special edition (23)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3630)
State (2)
Stomach cancer (18)
Supply chain (117)
Tariffs (86)
The Weekly (58)
Vaccines (1057)
Venture capital (98)
Weight loss (420)
Women's health (109)
Worklife (19)
Date
Today (12)
Last 7 days (637)
Last 30 days (2642)
Last 365 days (29946)
2026 (7994)
2025 (30210)
2024 (35243)
2023 (40104)
2022 (51215)
2021 (55758)
2020 (54123)
2019 (46607)
2018 (35103)
2017 (32174)
2016 (31540)
2015 (37607)
2014 (31379)
2013 (26414)
2012 (28624)
2011 (29319)
2010 (27373)
Location
Africa (741)
Alabama (90)
Alaska (7)
Arizona (331)
Arkansas (13)
Asia (39534)
Australia (6463)
California (12244)
Canada (3511)
China (1225)
Colorado (522)
Connecticut (520)
Delaware (366)
Europe (85477)
Florida (1871)
Georgia (394)
Hawaii (3)
Idaho (62)
Illinois (956)
India (80)
Indiana (558)
Iowa (22)
Japan (486)
Kansas (129)
Kentucky (44)
Louisiana (39)
Maine (73)
Maryland (1484)
Massachusetts (8751)
Michigan (346)
Minnesota (675)
Mississippi (6)
Missouri (138)
Montana (33)
Nebraska (29)
Nevada (135)
New Hampshire (82)
New Jersey (3267)
New Mexico (28)
New York (3233)
North Carolina (1554)
North Dakota (8)
Northern California (6054)
Ohio (365)
Oklahoma (22)
Oregon (41)
Pennsylvania (2483)
Puerto Rico (26)
Rhode Island (50)
South America (1115)
South Carolina (76)
South Dakota (1)
Southern California (4812)
Tennessee (199)
Texas (1924)
United States (43415)
Utah (368)
Vermont (1)
Virginia (291)
Washington D.C. (80)
Washington State (981)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
727,370 Results for "fortuna fix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer’s Therapies with Broad CNS Delivery Applications
March 26, 2026
·
2 min read
Rare diseases
PepGen Loses Half of Share Price on Mixed Data in Rare Muscle-Wasting Disease
PepGen’s lead candidate for myotonic dystrophy type 1 barely beat the placebo in a Phase 2 trial in terms of fixing incorrect gene splicing, but the biotech attributed the poor result to an outlier.
March 31, 2026
·
2 min read
·
Heather McKenzie
Press Releases
CALQUENCE® plus venetoclax approved in the US as first all-oral, fixed-duration combination for patients with chronic lymphocytic leukemia in the 1st-line setting
February 20, 2026
·
15 min read
Press Releases
Sagimet Biosciences and TAPI Announce Global License Agreement for Innovative Forms of Resmetirom API for Sagimet’s Fixed Dose Combination Program
December 17, 2025
·
8 min read
Opinion
Fixing the IRA’s Pill Penalty Is Critical to Supporting Small Molecule Innovation
Price-negotiation provisions that are out of step with reality are discouraging funders and Big Pharma partners from investing in potentially transformative therapies. Fixing some of the unintended consequences of the IRA will clear the way for innovative medicines to reach patients in need.
February 25, 2025
·
6 min read
·
Thomas M. Kaiser
Opinion
Fixing CGT Manufacturing Requires Not Automation, but a Return to Basics
The primary focus in scaling up production should first be the adoption of lean manufacturing principles used in virtually every other industry.
August 5, 2025
·
5 min read
·
Josh Ludwig
Press Releases
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
December 8, 2025
·
16 min read
Press Releases
Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025
November 10, 2025
·
11 min read
Press Releases
Daiichi Sankyo Announces the Development of a Fixed-Triple Combination Lipid-Lowering Tablet to Address Persistent Gaps in the Management of Elevated LDL-C
September 1, 2025
·
6 min read
Press Releases
Qlaris Bio Announces Development of Fixed-Dose Combination Therapy with QLS‑111 and Latanoprost for the Treatment of Glaucoma
June 11, 2025
·
3 min read
1 of 72,737
Next
